Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas McLaughlin

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Annals of Emergency Medicine|December 24, 2019
Implementation of Evidence-Based Practice for Benign Paroxysmal Positional Vertigo in the Emergency Department: A Stepped-Wedge Randomized TrialKevin A Kerber, Laura Damschroder, Thomas McLaughlin, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary NoteKenneth Blum, Marlene Oscar-Berman, John Femino, et al.
Journal of Addiction Psychiatry|February 14, 2025
Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty CasesKenneth Blum, Thomas Mclaughlin, Kai Uwe Lewandrowski, et al.
Journal of Personalized Medicine|October 27, 2022
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?Kenneth Blum, Catherine A Dennen, Igor Elman, et al.
Current Psychopharmacology|October 28, 2021
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain DevelopmentKenneth Blum, Abdalla Bowirrat, Marjorie C Gondre Lewis, et al.
Journal of Personalized Medicine|December 23, 2022
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent OpioidsMauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Personalized Medicine|December 29, 2022
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity IndexKenneth Blum, David Han, Abdalla Bowirrat, et al.
Journal of the Neurological Sciences|September 9, 2022
Why haven't we solved the addiction crisis?Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Journal of Personalized Medicine|February 25, 2022
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
EC Psychology and Psychiatry|June 26, 2023
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) BehaviorsKenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Annals of Emergency Medicine|December 24, 2019
Implementation of Evidence-Based Practice for Benign Paroxysmal Positional Vertigo in the Emergency Department: A Stepped-Wedge Randomized TrialKevin A Kerber, Laura Damschroder, Thomas McLaughlin, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary NoteKenneth Blum, Marlene Oscar-Berman, John Femino, et al.
Journal of Addiction Psychiatry|February 14, 2025
Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty CasesKenneth Blum, Thomas Mclaughlin, Kai Uwe Lewandrowski, et al.
Journal of Personalized Medicine|October 27, 2022
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?Kenneth Blum, Catherine A Dennen, Igor Elman, et al.
Current Psychopharmacology|October 28, 2021
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain DevelopmentKenneth Blum, Abdalla Bowirrat, Marjorie C Gondre Lewis, et al.
Journal of Personalized Medicine|December 23, 2022
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent OpioidsMauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Personalized Medicine|December 29, 2022
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity IndexKenneth Blum, David Han, Abdalla Bowirrat, et al.
Journal of the Neurological Sciences|September 9, 2022
Why haven't we solved the addiction crisis?Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Journal of Personalized Medicine|February 25, 2022
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
EC Psychology and Psychiatry|June 26, 2023
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) BehaviorsKenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
Pageof 7